Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 160

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: A prospective double blind placebo-controlled randomized trial

Cappello, G., Spezzaferro, M., Grossi, L., Manzoli, L., Marzio, L.·2007·Digestive and Liver Disease
DOI 10.1016/j.dld.2007.02.006
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.dld.2007.02.006

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 26

  1. Frissora, 2005, Symptom overlap and comorbidity of irritable bowel syndrome with other conditions, Curr Gastroenterol Rep, 7, 264, 10.1007/s11894-005-0018-9 · DOI
  2. Pimentel, 2003, Breath testing to evaluate lactose intolerance in irritable bowel syndrome correlates with lactulose testing and may not reflect true lactose malabsorption, Am J Gastroenterol, 98, 2700, 10.1111/j.1572-0241.2003.08670.x · DOI
  3. Vernia, 2001, Lactose malabsorption, irritable bowel syndrome and self-reported milk intolerance, Dig Liver Dis, 33, 234, 10.1016/S1590-8658(01)80713-1 · DOI
  4. Ojetti, 2005, High prevalence of celiac disease in patients with lactose intolerance, Digestion, 71, 106, 10.1159/000084526 · DOI
  5. De Giorgio, 2004, Diagnosis and therapy of irritable bowel syndrome, Aliment Pharmacol Ther, 20, 10, 10.1111/j.1365-2036.2004.02038.x · DOI
  6. Kline, 2001, Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children, J Pediatr, 138, 125, 10.1067/mpd.2001.109606 · DOI · Paper page
  7. Liu, 1997, Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial, J Gastroenterol, 32, 765, 10.1007/BF02936952 · DOI · Paper page
  8. Pittler, 1998, Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis, Am J Gastroenterol, 93, 1131, 10.1111/j.1572-0241.1998.00343.x · DOI · Paper page
  9. Ringel, 2001, Irritable bowel syndrome, Annu Rev Med, 52, 319, 10.1146/annurev.med.52.1.319 · DOI
  10. Lesbros-Pantoflickova, 2004, Meta-analysis: the treatment of irritable bowel syndrome, Aliment Pharmacol Ther, 20, 1253, 10.1111/j.1365-2036.2004.02267.x · DOI
  11. Hussain, 2006, Systematic review: complementary and alternative medicine in the irritable bowel syndrome, Aliment Pharmacol Ther, 23, 465, 10.1111/j.1365-2036.2006.02776.x · DOI
  12. Nash, 1986, Peppermint oil does not relieve the pain of irritable bowel syndrome, Br J Clin Pract, 40, 292, 10.1111/j.1742-1241.1986.tb07981.x · DOI
  13. Carling, 1989, Short term treatment of the irritable bowel syndrome: a placebo-controlled trial of peppermint oil against hyoschamine, OPMEAR, 34, 55
  14. Dew, 1984, Peppermint oil for the irritable bowel syndrome: a multicentre trial, Br J Clin Pract, 38, 394, 10.1111/j.1742-1241.1984.tb07744.x · DOI
  15. Lech, 1988, Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo, Ugeskr Laeger, 150, 2388
  16. Rees, 1979, Treating irritable bowel syndrome with peppermint oil, Br Med J, 6194, 835, 10.1136/bmj.2.6194.835 · DOI
  17. Farup, 2004, Lactose malabsorption in a population with irritable bowel syndrome: prevalence and symptoms. A case-control study, Scand J Gastroenterol, 39, 645, 10.1080/00365520410005405 · DOI
  18. Peralta, 2006, Small intestinal bacterial overgrowth: a new face of irritable bowel syndrome?, Dig Liver Dis, 38, S203, 10.1016/S1590-8658(06)80552-9 · DOI
  19. Hills, 1991, The mechanism of action of peppermint oil on gastrointestinal smooth muscle, Gastroenterology, 101, 55, 10.1016/0016-5085(91)90459-X · DOI
  20. Grigoleit, 2005, Gastrointestinal clinical pharmacology of peppermint oil, Phytomedicine, 12, 607, 10.1016/j.phymed.2004.10.006 · DOI
  21. Snape, 1997, Role of colonic motility in guiding therapy in patients with constipation, Dig Dis, 15, 104, 10.1159/000171625 · DOI
  22. Nobaek, 2000, Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome, Am J Gastroenterol, 95, 1231, 10.1111/j.1572-0241.2000.02015.x · DOI · Paper page
  23. Pimentel, 2003, Methane production during lactulose breath test is associated with gastrointestinal disease presentation, Dig Dis Sci, 48, 86, 10.1023/A:1021738515885 · DOI
  24. Logan, 2002, The treatment of small intestinal bacterial overgrowth with enteric-coated peppermint oil: a case report, Altern Med Rev, 7, 410
  25. Whorwell, 2006, Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome, Am J Gastroenterol, 101, 1581, 10.1111/j.1572-0241.2006.00734.x · DOI · Paper page
  26. Santos Ocampo, 1993, A randomized double-blind clinical trial of a maltodextrin-containing oral rehydration solution in acute infantile diarrhea, J Pediatr Gastroenterol Nutr, 16, 23, 10.1097/00005176-199301000-00004 · DOI

Cited by

Metadata

Authors
Cappello, G., Spezzaferro, M., Grossi, L., Manzoli, L., & Marzio, L.
Venue
Digestive and Liver Disease
Publisher
Elsevier BV
Published
2007-06
Volume
39
Issue
6
Pages
530-536
ISSN
1590-8658
DOI
10.1016/j.dld.2007.02.006
Cited by
160
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.